A soluble microneedle loaded with estradiol microemulsion and preparation method thereof
By combining estradiol microemulsion with a gel matrix, soluble microneedles were prepared, solving the problems of insufficient drug loading and stability of microneedles, and achieving improved drug loading, painless drug delivery, and transdermal efficiency.
Patent Information
- Application Number
- CN202210054435.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-01-18
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2042-01-18
AI Technical Summary
Existing microneedles have difficulty in stably loading drugs that are poorly soluble in water, affecting the drug loading capacity and stability. At the same time, their toughness and mechanical strength are insufficient, resulting in inconvenience and intense pain during the drug delivery process.
Soluble microneedles loaded with estradiol microemulsion were prepared by combining an oil-in-water microemulsion with a gel matrix. The base fluid was formed by mixing emulsifiers and freeze-thaw crosslinking, which improved the drug loading and stability, and enhanced the toughness and mechanical strength of the microneedles.
This approach achieves high drug loading and stability of estradiol in microneedles, improves transdermal efficiency, enables painless drug delivery, and broadens the application scope of microneedles.
Smart Images

Figure CN114344700B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of biomedical materials, and in particular to a soluble microneedle loaded with estradiol microemulsion and a preparation method thereof. Background Art
[0002] Microneedles have a sharp needle tip structure, which causes less damage to living organisms and greatly reduces the infection of living tissues. The shorter length of microneedles will not touch the human body's nerve receptor tissue, which can reduce the patient's pain during healing. Minimally invasive, timed, and quantitative drug delivery can improve transcutaneous permeability.
[0003] However, due to the characteristics of the microneedle structure, the microneedle can only carry a small amount of drugs with good stability. For drugs that are insoluble in water, directly adding them into the microneedle matrix will affect the toughness and brittleness of the microneedle and the stability of the drug. Therefore, soluble microneedles loaded with estradiol microemulsions have been developed. Loading water-insoluble drugs into oil-in-water microemulsions can increase the drug loading and stability. The oil-in-water microemulsion has good compatibility with the gel matrix, which can adjust the toughness and mechanical strength of the microneedles to achieve painless drug delivery. Summary of the invention
[0004] The present invention provides a soluble microneedle loaded with estradiol microemulsion and a preparation method thereof. The microneedle has good toughness and mechanical strength, is not easy to break, can pierce human skin for drug administration, improves the drug loading amount and skin penetration rate of estradiol, is convenient, quick and painless to use, has a simple preparation process and low production cost.
[0005] In order to achieve the above object, the present invention provides the following technical solutions:
[0006] A soluble microneedle loaded with estradiol microemulsion comprises a microneedle, characterized in that: the microneedle is loaded with a mixed base liquid made of microemulsion and gel, the raw materials of the microemulsion include estradiol, polyethylene glycol 400, 15-hydroxystearate polyethylene glycol or caprylic capric acid polyethylene glycol glyceride and isopropyl myristate; the raw materials of the gel include PVA and PVPK30.
[0007] Furthermore, the drug carried by the soluble microneedles is a drug that is poorly soluble in water.
[0008] A method for preparing soluble microneedles loaded with estradiol microemulsion, characterized in that it comprises the following steps:
[0009] Step 1, 15-hydroxystearic acid polyethylene glycol or caprylic acid capric acid polyethylene glycol glyceride, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60° C., 15-hydroxystearic acid polyethylene glycol or caprylic acid capric acid polyethylene glycol glyceride, and polyethylene glycol 400 are uniformly mixed as a mixed emulsifier, estradiol is weighed and dissolved in the mixed emulsifier, isopropyl myristate is added, and then distilled water is added dropwise at a certain speed under constant temperature magnetic stirring to prepare a microemulsion;
[0010] Step 2: After cooling the microemulsion obtained in step 1 to room temperature, the microemulsion is evenly mixed with an aqueous solution of PVA and PVP K30, and after freeze-thawing, the mixture is placed in a PDMS microneedle mold, centrifuged, dried, and the film is removed to obtain a soluble microneedle loaded with estradiol microemulsion.
[0011] Furthermore, in step 1, the ratio of 15-hydroxystearic acid polyethylene glycol or caprylic acid capric acid polyethylene glycol glyceride to polyethylene glycol is 1:1 to 3:1.
[0012] Furthermore, in step 1, the content of estradiol is 0.2% to 0.8%.
[0013] Furthermore, in step 1, the content of the mixed emulsifier is 25.9% to 54.5%, the content of isopropyl myristate is 8.0% to 11.6%, and the content of distilled water is 33.1% to 65.9%.
[0014] Furthermore, in step 1, the conditions for preparing the microemulsion are: temperature of 30-50° C., stirring speed of 600-1000 rpm / min, and distilled water dropping speed of 0.5-1 ml / min.
[0015] Furthermore, in step 2, the content of the microemulsion is 20% to 25%, the content of the PVA is 32% to 34%, and the content of the PVP K30 is 43% to 46%.
[0016] Furthermore, in step 2, the concentration of the PVA is 20%, and the concentration of the PVP K30 is 30% to 40%.
[0017] Furthermore, in step 2, the mixed gel obtained by mixing the microemulsion with the aqueous solution of PVA and PVP K30 was freeze-thawed twice, with the freezing condition being 1 hour and the thawing condition being 0.5 hour, and then cross-linked and solidified.
[0018] Furthermore, in step 2, the microneedles are dried in an oven at 40°C.
[0019] Furthermore, the length of the microneedle is 300 to 900 μm.
[0020] Compared with the prior art, the present invention has the following beneficial effects:
[0021] 1. The present invention designs and prepares a soluble microneedle loaded with estradiol microemulsion. By mixing the microemulsion and gel and cross-linking them by freeze-thawing to form a base liquid, a microneedle with good toughness and mechanical strength is prepared, which can pierce and adhere to the skin, thereby achieving the purpose of long-term drug delivery and sustained release.
[0022] 2. The soluble microneedles of the estradiol microemulsion designed by the present invention can increase the content of estradiol in the microneedles.
[0023] 3. The soluble microneedles of the estradiol microemulsion designed by the present invention, in which estradiol is encapsulated in the microemulsion, can improve the stability of estradiol in the microneedles.
[0024] 4. The soluble microneedles of the estradiol microemulsion designed by the present invention can improve the transdermal efficiency of estradiol.
[0025] 5. The soluble microneedles of the estradiol microemulsion designed by the present invention carry drugs that are poorly soluble in water, and are suitable for combining other poorly soluble drugs with the microneedles, thereby broadening the scope of application of the microneedles.
[0026] 6. The soluble microneedles of the estradiol microemulsion designed by the present invention can achieve safe, effective and autonomous drug delivery. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1 This is a flow chart of a method for preparing a soluble microneedle loaded with estradiol microemulsion according to the present invention;
[0028] Figure 2 Microscopic picture of the soluble microneedles loaded with estradiol microemulsion prepared in Example 1 of the present invention.
[0029] Figure 3 Macroscopic picture of the soluble microneedles loaded with estradiol microemulsion prepared in Example 1 of the present invention. DETAILED DESCRIPTION
[0030] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.
[0031] Example 1
[0032] This embodiment 1 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0033] Step 1, 15-hydroxystearic acid polyethylene glycol, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60°C, 15-hydroxystearic acid polyethylene glycol and polyethylene glycol 400 are mixed in a ratio of 1:1 as a mixed emulsifier, 0.2% estradiol is weighed and dissolved in 25.9% of the mixed emulsifier, 8.0% isopropyl myristate is added, and then 65.9% distilled water is added dropwise at a speed of 1 ml / min under constant temperature magnetic stirring (40°C, 800 rpm / min) to prepare a microemulsion;
[0034] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is mixed evenly with 20% PVA and 40% PVP K30 aqueous solution in a ratio of 32:43:25, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the microemulsion is placed in a 600 μm PDMS microneedle mold, centrifuged in a flat centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 24 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0035] Example 2
[0036] This embodiment 2 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0037] Step 1, 15-hydroxystearic acid polyethylene glycol, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60°C, 15-hydroxystearic acid polyethylene glycol and polyethylene glycol 400 are mixed evenly in a ratio of 2:1 as a mixed emulsifier, 0.2% estradiol is weighed and dissolved in 25.9% of the mixed emulsifier, 8.0% isopropyl myristate is added, and then 65.9% distilled water is added dropwise at a speed of 1 ml / min under constant temperature magnetic stirring (40°C, 800 rpm / min) to prepare a microemulsion.
[0038] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is mixed evenly with 20% PVA and 40% PVP K30 aqueous solution in a ratio of 32:43:25, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the microemulsion is placed in a 600 μm PDMS microneedle mold, centrifuged in a flat centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 24 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0039] Example 3
[0040] This embodiment 3 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0041] Step 1, 15-hydroxystearic acid polyethylene glycol, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60°C, 15-hydroxystearic acid polyethylene glycol and polyethylene glycol 400 are mixed evenly in a ratio of 3:1 as a mixed emulsifier, 0.2% estradiol is weighed and dissolved in 25.9% of the mixed emulsifier, 8.0% isopropyl myristate is added, and then 65.9% distilled water is added dropwise at a speed of 1 ml / min under constant temperature magnetic stirring (40°C, 800 rpm / min) to prepare a microemulsion.
[0042] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is mixed evenly with 20% PVA and 40% PVP K30 aqueous solution in a ratio of 32:43:25, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the microemulsion is placed in a 600 μm PDMS microneedle mold, centrifuged in a flat centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 24 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0043] Example 4
[0044] This embodiment 4 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0045] Step 1, 15-hydroxystearic acid polyethylene glycol, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60°C, 15-hydroxystearic acid polyethylene glycol and polyethylene glycol 400 are mixed evenly in a ratio of 3:1 as a mixed emulsifier, 0.2% estradiol is weighed and dissolved in 25.9% of the mixed emulsifier, 8.0% isopropyl myristate is added, and then 65.9% distilled water is added dropwise at a speed of 1 ml / min under constant temperature magnetic stirring (40°C, 600 rpm / min) to prepare a microemulsion.
[0046] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is mixed evenly with 20% PVA and 40% PVP K30 aqueous solution in a ratio of 32:43:25, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the microemulsion is placed in a 600 μm PDMS microneedle mold, centrifuged in a flat centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 24 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0047] Example 5
[0048] This embodiment 5 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0049] Step 1, 15-hydroxystearic acid polyethylene glycol, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60°C, 15-hydroxystearic acid polyethylene glycol and polyethylene glycol 400 are mixed evenly in a ratio of 3:1 as a mixed emulsifier, 0.2% estradiol is weighed and dissolved in 25.9% of the mixed emulsifier, 8.0% isopropyl myristate is added, and then 65.9% distilled water is added dropwise at a speed of 1 ml / min under constant temperature magnetic stirring (40°C, 1000 rpm / min) to prepare a microemulsion.
[0050] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is mixed evenly with 20% PVA and 40% PVP K30 aqueous solution in a ratio of 32:43:25, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the microemulsion is placed in a 600 μm PDMS microneedle mold, centrifuged in a flat centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 24 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0051] Example 6
[0052] This embodiment 6 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0053] Step 1, 15-hydroxystearic acid polyethylene glycol, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60°C, 15-hydroxystearic acid polyethylene glycol and polyethylene glycol 400 are mixed evenly in a ratio of 3:1 as a mixed emulsifier, 0.2% estradiol is weighed and dissolved in 25.9% of the mixed emulsifier, 8.0% isopropyl myristate is added, and then 65.9% distilled water is added dropwise at a speed of 0.5 ml / min under constant temperature magnetic stirring (40°C, 800 rpm / min) to prepare a microemulsion.
[0054] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is mixed evenly with 20% PVA and 40% PVP K30 aqueous solution in a ratio of 32:43:25, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the microemulsion is placed in a 600 μm PDMS microneedle mold, centrifuged in a flat centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 24 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0055] Example 7
[0056] This embodiment 7 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0057] Step 1, 15-hydroxystearic acid polyethylene glycol, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60°C, 15-hydroxystearic acid polyethylene glycol and polyethylene glycol 400 are mixed evenly in a ratio of 3:1 as a mixed emulsifier, 0.2% estradiol is weighed and dissolved in 25.9% of the mixed emulsifier, 8.0% isopropyl myristate is added, and then 65.9% distilled water is added dropwise at a speed of 1 ml / min under constant temperature magnetic stirring (40°C, 800 rpm / min) to prepare a microemulsion.
[0058] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is evenly mixed with 20% PVA and 40% PVP K30 aqueous solution in a ratio of 32:43:25, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the microemulsion is placed in a 300 μm PDMS microneedle mold, centrifuged in a flat centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 24 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0059] Example 8
[0060] This embodiment 8 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0061] Step 1, 15-hydroxystearic acid polyethylene glycol, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60°C, 15-hydroxystearic acid polyethylene glycol and polyethylene glycol 400 are mixed evenly in a ratio of 3:1 as a mixed emulsifier, 0.2% estradiol is weighed and dissolved in 25.9% of the mixed emulsifier, 8.0% isopropyl myristate is added, and then 65.9% distilled water is added dropwise at a speed of 1 ml / min under constant temperature magnetic stirring (40°C, 800 rpm / min) to prepare a microemulsion.
[0062] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is evenly mixed with 20% PVA and 40% PVP K30 aqueous solution in a ratio of 32:43:25, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the microemulsion is placed in a 900 μm PDMS microneedle mold, centrifuged in a flat centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 24 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0063] Example 9
[0064] This embodiment 9 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0065] Step 1, caprylic acid capric acid macrogol glyceride, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60°C, caprylic acid capric acid macrogol glyceride and polyethylene glycol 400 are mixed evenly in a ratio of 1:1 as a mixed emulsifier, 0.8% estradiol is weighed and dissolved in 54.5% of the mixed emulsifier, 11.6% isopropyl myristate is added, and then 33.1% distilled water is added dropwise at a speed of 1 ml / min under constant temperature magnetic stirring (40°C, 800 rpm / min) to prepare a microemulsion.
[0066] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is evenly mixed with 20% PVA and 30% PVP K30 aqueous solution in a ratio of 34:46:20, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the mixture is placed in a 600 μm PDMS microneedle mold, centrifuged in a flat plate centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 48 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0067] Example 10
[0068] This embodiment 10 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0069] Step 1, caprylic acid capric acid macrogol glyceride, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60°C, caprylic acid capric acid macrogol glyceride and polyethylene glycol 400 are mixed evenly in a ratio of 2:1 as a mixed emulsifier, 0.8% estradiol is weighed and dissolved in 54.5% of the mixed emulsifier, 11.6% isopropyl myristate is added, and then 33.1% distilled water is added dropwise at a speed of 1 ml / min under constant temperature magnetic stirring (40°C, 800 rpm / min) to prepare a microemulsion.
[0070] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is evenly mixed with 20% PVA and 30% PVP K30 aqueous solution in a ratio of 34:46:20, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the mixture is placed in a 600 μm PDMS microneedle mold, centrifuged in a flat plate centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 48 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0071] Embodiment 11
[0072] This embodiment 11 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0073] Step 1, caprylic acid capric acid macrogol glyceride, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60°C, caprylic acid capric acid macrogol glyceride and polyethylene glycol 400 are mixed evenly in a ratio of 3:1 as a mixed emulsifier, 0.8% estradiol is weighed and dissolved in 54.5% of the mixed emulsifier, 11.6% isopropyl myristate is added, and then 33.1% distilled water is added dropwise at a speed of 1 ml / min under constant temperature magnetic stirring (40°C, 800 rpm / min) to prepare a microemulsion.
[0074] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is evenly mixed with 20% PVA and 30% PVP K30 aqueous solution in a ratio of 34:46:20, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the mixture is placed in a 600 μm PDMS microneedle mold, centrifuged in a flat plate centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 48 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0075] Example 12
[0076] This embodiment 12 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0077] Step 1, caprylic acid capric acid macrogol glyceride, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60° C., caprylic acid capric acid macrogol glyceride and polyethylene glycol 400 are uniformly mixed in a ratio of 3:1 as a mixed emulsifier, 0.8% estradiol is weighed and dissolved in 54.5% of the mixed emulsifier, 11.6% isopropyl myristate is added, and then 33.1% distilled water is added dropwise at a speed of 1 ml / min under constant temperature magnetic stirring (40° C., 600 rpm / min) to prepare a microemulsion.
[0078] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is evenly mixed with 20% PVA and 30% PVP K30 aqueous solution in a ratio of 34:46:20, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the mixture is placed in a 600 μm PDMS microneedle mold, centrifuged in a flat plate centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 48 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0079] Embodiment 13
[0080] This embodiment 13 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0081] Step 1, caprylic acid capric acid macrogol glyceride, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60°C, caprylic acid capric acid macrogol glyceride and polyethylene glycol 400 are mixed evenly in a ratio of 3:1 as a mixed emulsifier, 0.8% estradiol is weighed and dissolved in 54.5% of the mixed emulsifier, 11.6% isopropyl myristate is added, and then 33.1% distilled water is added dropwise at a speed of 1 ml / min under constant temperature magnetic stirring (40°C, 800 rpm / min) to prepare a microemulsion.
[0082] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is evenly mixed with 20% PVA and 30% PVP K30 aqueous solution in a ratio of 34:46:20, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the mixture is placed in a 600 μm PDMS microneedle mold, centrifuged in a flat plate centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 48 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0083] Embodiment 14
[0084] This embodiment 14 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0085] Step 1, caprylic acid capric acid macrogol glyceride, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60°C, caprylic acid capric acid macrogol glyceride and polyethylene glycol 400 are mixed evenly in a ratio of 3:1 as a mixed emulsifier, 0.8% estradiol is weighed and dissolved in 54.5% of the mixed emulsifier, 11.6% isopropyl myristate is added, and then 33.1% distilled water is added dropwise at a speed of 1 ml / min under constant temperature magnetic stirring (40°C, 1000 rpm / min) to prepare a microemulsion.
[0086] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is evenly mixed with 20% PVA and 30% PVP K30 aqueous solution in a ratio of 34:46:20, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the mixture is placed in a 600 μm PDMS microneedle mold, centrifuged in a flat plate centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 48 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0087] Embodiment 15
[0088] This embodiment 15 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0089] Step 1, caprylic acid capric acid macrogol glyceride, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60° C., caprylic acid capric acid macrogol glyceride and polyethylene glycol 400 are mixed evenly in a ratio of 3:1 as a mixed emulsifier, 0.8% estradiol is weighed and dissolved in 54.5% of the mixed emulsifier, 11.6% isopropyl myristate is added, and then 33.1% distilled water is added dropwise at a speed of 0.5 ml / min under constant temperature magnetic stirring (40° C., 800 rpm / min) to prepare a microemulsion.
[0090] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is evenly mixed with 20% PVA and 30% PVP K30 aqueous solution in a ratio of 34:46:20, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the mixture is placed in a 600 μm PDMS microneedle mold, centrifuged in a flat plate centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 48 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0091] Example 16
[0092] This embodiment 16 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0093] Step 1, caprylic acid capric acid macrogol glyceride, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60° C., caprylic acid capric acid macrogol glyceride and polyethylene glycol 400 are mixed evenly in a ratio of 3:1 as a mixed emulsifier, 0.8% estradiol is weighed and dissolved in 54.5% of the mixed emulsifier, 11.6% isopropyl myristate is added, and then 33.1% distilled water is added dropwise at a speed of 0.5 ml / min under constant temperature magnetic stirring (40° C., 800 rpm / min) to prepare a microemulsion.
[0094] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is evenly mixed with 20% PVA and 30% PVP K30 aqueous solution in a ratio of 34:46:20, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the mixture is placed in a 300 μm PDMS microneedle mold, centrifuged in a flat plate centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 48 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0095] Embodiment 17
[0096] This embodiment 17 provides a method for preparing a soluble microneedle loaded with estradiol microemulsion, comprising the following steps:
[0097] Step 1, caprylic acid capric acid macrogol glyceride, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60° C., caprylic acid capric acid macrogol glyceride and polyethylene glycol 400 are mixed evenly in a ratio of 3:1 as a mixed emulsifier, 0.8% estradiol is weighed and dissolved in 54.5% of the mixed emulsifier, 11.6% isopropyl myristate is added, and then 33.1% distilled water is added dropwise at a speed of 0.5 ml / min under constant temperature magnetic stirring (40° C., 800 rpm / min) to prepare a microemulsion.
[0098] Step 2: After the microemulsion obtained in step 1 is cooled to room temperature, the microemulsion is evenly mixed with 20% PVA and 30% PVP K30 aqueous solution in a ratio of 34:46:20, and frozen for 1 hour and thawed for 0.5 hour as one freeze-thaw cycle. After two freeze-thaw cycles, the microemulsion is placed in a 900 μm PDMS microneedle mold, centrifuged in a flat centrifuge (2500 rpm, 25 min), dried in an oven at 40°C for 48 hours, and the film is removed to obtain soluble microneedles loaded with estradiol microemulsion.
[0099] The above are only preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A soluble microneedle loaded with estradiol microemulsion, comprising a microneedle, characterized in that : The microneedles are loaded with a mixed base liquid made of microemulsion and gel, the raw materials of the microemulsion include estradiol, polyethylene glycol 400, 15-hydroxystearic acid polyethylene glycol or caprylic acid capric acid polyethylene glycol glyceride and isopropyl myristate; the raw materials of the gel include PVA and PVP K30; A method for preparing a soluble microneedle loaded with estradiol microemulsion comprises the following steps: Step 1, 15-hydroxystearic acid polyethylene glycol or caprylic acid capric acid polyethylene glycol glyceride, polyethylene glycol 400, and isopropyl myristate are placed in an oven and heated to 60°C, 15-hydroxystearic acid polyethylene glycol or caprylic acid capric acid polyethylene glycol glyceride, and polyethylene glycol 400 are mixed evenly as a mixed emulsifier, estradiol is weighed and dissolved in the mixed emulsifier, isopropyl myristate is added, and then distilled water is added dropwise at a certain speed under constant temperature magnetic stirring to prepare a microemulsion; the 15-hydroxystearic acid polyethylene glycol or caprylic acid capric acid polyethylene glycol glyceride is added dropwise at a certain speed to prepare a microemulsion; The ratio of ester polyethylene glycol glyceride to polyethylene glycol is 1:1-3:1; the content of estradiol is 0.2%-0.8%; the content of the mixed emulsifier is 25.9%-54.5%, the content of isopropyl myristate is 8.0%-11.6%, and the content of distilled water is 33.1%-65.9%; the conditions for preparing the microemulsion are: temperature of 30-50°C, stirring speed of 600-1000rpm / min, and the speed of adding distilled water is 0.5-1ml / min; Step 2: After cooling the microemulsion obtained in step 1 to room temperature, the microemulsion is evenly mixed with an aqueous solution of PVA and PVP K30, and after freeze-thawing, the mixture is placed in a PDMS microneedle mold, centrifuged, dried, and the film is removed to obtain a soluble microneedle loaded with estradiol microemulsion; the content of the microemulsion is 20% to 25%, the content of the PVA is 32% to 34%, and the content of the PVP K30 is 43% to 46%; the concentration of the PVA is 20%, and the concentration of the PVP K30 is 30% to 40%; the mixed gel obtained by mixing the microemulsion with an aqueous solution of PVA and PVP K30 is freeze-thawed twice, with the freezing condition being 1 hour and the melting condition being 0.5 hour, and cross-linked and solidified; the drying method of the microneedle is oven drying at 40° C.; the length of the microneedle is 300 to 900 μm.
2. The soluble microneedle loaded with estradiol microemulsion according to claim 1, characterized in that The drug carried by the soluble microneedle is a drug that is poorly soluble in water.
